Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Celcuity to Participate in the Canaccord Genuity 41st Annual Growth Conference
-
Applied Molecular Transport to Present at Canaccord Genuity’s 41st Annual Growth Conference
-
Rhythm Pharmaceuticals to Present at 2021 Canaccord Genuity 41st Annual Growth Conference
-
Apex Fintech Solutions to Participate in the Canaccord Genuity 41st Annual Growth Conference
-
Kratos to Present at the Canaccord Genuity Virtual Growth Conference
-
CRISPR Therapeutics to Participate in the Canaccord Genuity 41st Annual Growth Conference
-
Surrozen to Present at Canaccord Genuity’s 41st Annual Growth Conference
-
Plus Therapeutics to Present at Canaccord Genuity 41st Annual Growth Conference
-
DocGo to Participate at Upcoming Virtual Investor Conferences
-
Penn National Gaming (PENN) Acquires Score Media and Gaming (SCR) for $2B in Cash and Stock
-
Penn National Gaming to Acquire Score Media and Gaming, Creating North America’s Leading Digital Sports Content, Gaming and Technology Company
-
Penn National Gaming to Acquire Score Media and Gaming, Creating North America’s Leading Digital Sports Content, Gaming and Technology Company
-
Seres Therapeutics to Present at Canaccord Genuity 41st Annual Growth Conference
-
Flow Beverage to Present at Canaccord Genuity Virtual Growth Conference
-
Landos Biopharma to Participate in Upcoming Investor Events
-
Form 8.3 - [Marlowe plc - 04 08 2021] - (CGWL)
-
Perion Network to Present at the Oppenheimer Conference on August 11 and Canaccord Genuity Conference on August 12
-
Dynamo Capital and Carespan Sign Definitive Agreement
-
T2 Biosystems to Participate in the Canaccord Genuity 41st Annual Growth Conference
-
Quanterix Corp. (QTRX) PT Lowered to $75 at Canaccord Genuity
-
Teladoc Health to Participate in Canaccord Genuity Growth Conference
-
Atreca to Present at Upcoming Virtual Investor Conferences
-
Walden Biosciences Announces Virtual Presentation at Canaccord Genuity 41st Annual Growth Conference
-
Zeta to Present at Upcoming Investor Conferences
-
Teladoc Health to Participate in Canaccord Genuity Growth Conference
-
Atreca to Present at Upcoming Virtual Investor Conferences
-
Blue Apron to Participate in the Canaccord Genuity 41st Annual Growth Conference
-
Sage Therapeutics to Present at Upcoming August Investor Conferences
-
REPAY to Attend Canaccord Genuity 41st Annual Growth Conference on August 12, 2021
-
Boxed to Participate in the Canaccord Genuity 41st Annual Growth Conference
-
Nuvei to Participate in Upcoming Investor Conferences
-
Boxed to Participate in the Canaccord Genuity 41st Annual Growth Conference
-
X4 Pharmaceuticals to Participate at Canaccord Genuity’s Virtual 41st Annual Growth Conference
-
Cree, Inc. to Participate in Canaccord Genuity’s 41st Annual Growth Conference
-
SailPoint To Participate in Canaccord Genuity 41st Annual Growth Conference
-
Zoominfo to Participate in Upcoming Investor Conference
-
Calyxt to Present at the Canaccord Genuity 41st Annual Growth Conference on August 11, 2021
-
ChemoCentryx to Participate in the Canaccord Genuity 41st Annual Growth Conference
-
ChemoCentryx to Participate in the Canaccord Genuity 41st Annual Growth Conference
-
Hamilton Thorne to Present at Canaccord Genuity 41st Annual Growth Conference
-
Hamilton Thorne to Present at Canaccord Genuity 41st Annual Growth Conference
-
AgroFresh Solutions to Present at the Canaccord Genuity 41st Annual Growth Conference
-
Neoleukin Therapeutics to Participate in Canaccord Genuity 41st Annual Growth Conference
-
Theratechnologies to Present at the Canaccord Genuity 41st Annual Growth Conference
-
BlackBerry to Participate in Upcoming Investor Conferences
-
Curaleaf Announces Presentation at the Canaccord Genuity 41st Annual Growth Conference
-
EQ Inc. to Present at Canaccord Genuity Annual Growth Conference
-
Theratechnologies to Present at the Canaccord Genuity 41st Annual Growth Conference
-
Neoleukin Therapeutics to Participate in Canaccord Genuity 41st Annual Growth Conference
-
Cortexyme to Present at Canaccord Genuity' s 41st Annual Growth Conference on August 11th

